Gaffar Shayista, Ashraf S M, Riaz Ufana
Materials Research Laboratory, Department of Chemistry, Jamia Millia Islamia, New Delhi, 110025 India.
Department of Chemistry and Biochemistry, North Carolina Central University, Durham, NC 27707 USA.
J Environ Health Sci Eng. 2024 Dec 28;23(1):6. doi: 10.1007/s40201-024-00931-z. eCollection 2025 Jun.
Metformin, a widely used antidiabetic drug, has become a growing concern due to its persistence in the environment. It is one of the most frequently detected pharmaceuticals in wastewater and surface water because it is excreted largely unchanged by patients and is not fully removed in conventional wastewater treatment plants. The present study focuses on the synthesis and characterization of BaFeO/poly(1-naphthylamine) (PNA) nanohybrids and their application as microwave-active catalysts for the degradation of metformin. The nanohybrids were analyzed using scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), and X-ray diffraction (XRD) techniques. The IR studies presence of peaks associated with PNA and BaFeO confirmed the formation of the nanohybrid. The XRD profile of PNA/BaFeO nanohybrids did not exhibit any significant shift in the crystalline peaks corresponding to BaFeO but some new peaks were observed in addition to the existing BaFeO peaks, which were attributed to the presence of PNA. SEM studies established the mixed morphology. Metformin degradation was carried out under microwave irradiation for 18 min, and the effects of catalyst dosage and drug concentration were evaluated to confirm the catalytic performance of the PNA/BaFeO system. A maximum degradation efficiency of 89% was achieved in 18 min using 5% PNA/BaFeO as the catalyst. Additionally, a potential degradation mechanism was proposed.
The online version contains supplementary material available at 10.1007/s40201-024-00931-z.
二甲双胍是一种广泛使用的抗糖尿病药物,因其在环境中的持久性而日益受到关注。它是废水中和地表水中最常检测到的药物之一,因为患者排出的药物基本未发生变化,且在传统污水处理厂中不能被完全去除。本研究重点关注BaFeO/聚(1-萘胺)(PNA)纳米杂化物的合成与表征及其作为微波活性催化剂用于降解二甲双胍的应用。使用扫描电子显微镜(SEM)、傅里叶变换红外光谱(FT-IR)和X射线衍射(XRD)技术对纳米杂化物进行了分析。红外研究中与PNA和BaFeO相关的峰的存在证实了纳米杂化物的形成。PNA/BaFeO纳米杂化物的XRD图谱在对应于BaFeO的结晶峰处未显示出任何显著位移,但除了现有的BaFeO峰外还观察到了一些新峰,这归因于PNA的存在。SEM研究确定了混合形态。在微波辐射下进行二甲双胍降解18分钟,并评估催化剂用量和药物浓度的影响以确认PNA/BaFeO体系的催化性能。使用5%的PNA/BaFeO作为催化剂,在18分钟内实现了89%的最大降解效率。此外,还提出了一种潜在的降解机制。
在线版本包含可在10.1007/s40201-024-00931-z获取的补充材料。